Xigduo XR is a prescription medication combining dapagliflozin and metformin HCl in an extended-release tablet form. Each tablet contains 10mg of dapagliflozin and 1000mg of metformin HCl, with the package containing 30 tablets. This medication is manufactured, packed and released by AstraZeneca Pharmaceuticals LP in Mount Vernon, Indiana, USA. The marketing authorization is held by AstraZeneca AB in Södertälje Sweden. Xigduo is a registered trademark of the AstraZeneca group of companies. The extended-release formulation allows for controlled delivery of the active ingredients over time.